Johnson & Johnson pauses Covid-19 vaccine trial after “unexplained illness”
Drugmaker Johnson & Johnson said Monday it has paused the advanced clinical trial of its experimental coronavirus vaccine because of an unexplained illness in one of the volunteers.
“Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have prespecified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,” the company said.
You may be interested
Two Greek islands in best-hidden of the Mediterranean: TelegraphPanos - Jun 18, 2021
British media outlet Telegraph included the Greek islands of Karpathos and Alonissos in its top 20 holiday destinations in the…
Coronavirus Greece: 519 new cases, 321 intubated, 16 deathsPanos - Jun 18, 2021
Greece announced that the new laboratory-confirmed cases of coronavirus recorded in the last 24 hours are 519, of which 2…